Patents Assigned to Wisconsin Pharmacal Company, LLC
  • Patent number: 9011909
    Abstract: A composition for vaginal insertion is in the form of a softgel, a two-part gelatin capsule, a tablet, or a suppository. The composition is designed to promote the growth of native vaginal flora, but does not promote the growth of Gardenerella vaginalis and Candida albicans. The composition includes a prebiotic in a pharmaceutically acceptable excipient and is essentially free of probiotics, lactoferrin, and plant extracts containing isoflavones.
    Type: Grant
    Filed: September 2, 2011
    Date of Patent: April 21, 2015
    Assignee: Wisconsin Pharmacal Company, LLC
    Inventors: JoEllen Currie, Jean M. Young, John Wundrock
  • Patent number: 8266832
    Abstract: A label system including a label having a first portion which has a protective coating thereon and a second portion on a same side thereof which does not have the protective coating. The label further includes a generally transparent window, wherein the window is configured to overlie the second portion when the label is wrapped around a body.
    Type: Grant
    Filed: December 13, 2010
    Date of Patent: September 18, 2012
    Assignee: Wisconsin Pharmacal Company, LLC
    Inventor: James K. Markee
  • Publication number: 20120144709
    Abstract: A label system including a label having a first portion which has a protective coating thereon and a second portion on a same side thereof which does not have the protective coating. The label further includes a generally transparent window, wherein the window is configured to overlie the second portion when the label is wrapped around a body.
    Type: Application
    Filed: December 13, 2010
    Publication date: June 14, 2012
    Applicant: WISCONSIN PHARMACAL COMPANY, LLC
    Inventor: James K. Markee
  • Publication number: 20120058181
    Abstract: A composition for vaginal insertion is in the form of a softgel, a two-part gelatin capsule, a tablet, or a suppository. The composition is designed to promote the growth of native vaginal flora, but does not promote the growth of Gardenerella vaginalis and Candida albicans. The composition includes a prebiotic in a pharmaceutically acceptable excipient and is essentially free of probiotics, lactoferrin, and plant extracts containing isoflavones.
    Type: Application
    Filed: September 2, 2011
    Publication date: March 8, 2012
    Applicant: WISCONSIN PHARMACAL COMPANY, LLC
    Inventors: JoEllen Currie, Jean M. Young, John Wundrock